Symbiotec Pharmalab IPO GMP Today
Expected Gain: 29.86%
Symbiotec Pharmalab IPO GMP Today, 21 August 2026
Symbiotec Pharmalab IPO GMP today is ₹295. The latest grey market premium is ₹295 as of 21 August 2026.
With the IPO upper price band fixed at ₹988 per share, the current GMP indicates an estimated listing price of ₹1,283 per share.
Based on the current GMP, the estimated gain is approximately 29.86% over the IPO upper price band.
The GMP is based on unofficial grey-market activity and may change before the listing date. Investors should not consider GMP as a guarantee of the actual listing price.
Symbiotec Pharmalab IPO Expected Listing Price
IPO Upper Price Band: ₹988
Latest GMP: ₹295
Therefore, the current GMP indicates an estimated listing price of ₹1,283 per share.
Estimated gain over the upper price band: 29.86%
Symbiotec Pharmalab IPO GMP Trend
Symbiotec Pharmalab IPO GMP is currently reported at ₹295 as of 21 August 2026.
The IPO is scheduled to open for subscription on 24 August 2026. GMP may change during the subscription period depending on market sentiment and demand.
| GMP Date | IPO Price | GMP | Estimated Listing | Estimated Gain | Last Updated |
|---|---|---|---|---|---|
|
21-Aug-2026
Latest |
₹988 | ₹295 ▲ | ₹1,283 | 29.86% | 21-Aug-2026 |
* Estimated listing price is calculated using the IPO upper price band plus the latest GMP. GMP-based listing estimates are indicative and may differ from the actual listing price.
Symbiotec Pharmalab IPO Details
| IPO Name | Symbiotec Pharmalab IPO |
| Company | Symbiotec Pharmalab Ltd. |
| Sector | Pharmaceuticals, APIs & Biotechnology |
| IPO Type | Mainboard |
| Issue Type | Book Building Issue |
| Exchange | BSE, NSE |
| Open Date | 24 August 2026 |
| Close Date | 27 August 2026 |
| Allotment Date | 28 August 2026 |
| Listing Date | 1 September 2026 |
| Price Band | ₹938 – ₹988 per share |
| Face Value | ₹2 per share |
| Lot Size | 15 Shares |
| Minimum Investment | ₹14,820 |
| Total Issue Size | ₹1,757 crore |
| Fresh Issue | ₹150 crore |
| Offer for Sale | ₹1,607 crore |
| Latest GMP | ₹295 |
| Estimated Listing Price | ₹1,283 |
| Estimated Gain | 29.86% |
| Last GMP Update | 21 August 2026 |
Symbiotec Pharmalab IPO GMP Profit Estimate
Based on the current GMP of ₹295 and the upper IPO price band of ₹988, the estimated listing price is ₹1,283.
| Particular | Calculation | Amount |
|---|---|---|
| IPO Investment | ₹988 × 15 Shares | ₹14,820 |
| Estimated Listing Value | ₹1,283 × 15 Shares | ₹19,245 |
| Estimated Gain | ₹19,245 − ₹14,820 | ₹4,425 |
If the GMP remains at ₹295 until listing, one lot of 15 shares could indicate an estimated gain of approximately ₹4,425.
Symbiotec Pharmalab IPO GMP Update
GMP Date: 21 August 2026
Latest GMP: ₹295
The latest reported grey-market premium is ₹295 per share. Previous GMP data has not been included here unless separately reported.
What Is Symbiotec Pharmalab IPO GMP?
IPO GMP stands for Initial Public Offering Grey Market Premium. It represents the premium at which an IPO may be informally traded in the grey market before its official stock-market listing.
A positive GMP may indicate positive market sentiment toward the IPO, while a negative GMP may indicate expectations of a discounted listing.
However, the grey market is unofficial and unregulated. GMP can change significantly before the listing date and should not be treated as a guaranteed listing price.
₹988 + ₹295 = ₹1,283
Estimated Gain = (₹295 ÷ ₹988) × 100 = 29.86%
IPO GMP is based on unofficial grey-market indications and is provided for informational purposes only. GMP can change rapidly and does not guarantee the actual listing price or returns. The estimated listing price and gain shown above are calculated using the IPO upper price band and the reported GMP. Investors should conduct their own research and due diligence before making any investment decision.
